Macro and energy
The S&P 500 just logged its worst month since 2022. Megacap tech is flirting with correction territory, and the retail “buy the dip” reflex looks worn out. In this setup, rallies don’t get much follow-through—they get sold. The market is cutting exposure to long-duration stories and paying up less willingly for anything that relies on “later.”
Energy is still the swing variable because the backstop feels shaky. Trump signaled openness to ending military operations against Iran even as the Strait of Hormuz remains closed, and reports said he told allies the U.S. wouldn’t intervene further in oil-related conflicts while urging them to secure their own supplies. Net: nobody wants to bet on a quick policy fix, so supply-chain risk stays in the premium.
Europe is already feeling it. German May power prices are running about 4x French levels. That’s not a narrative—it's a direct hit to competitiveness for energy-intensive industry, and a reminder that inflation can come from constraints even when demand cools.
Tech and growth
No single disastrous print today. Just a stack of smaller frictions that keeps flows defensive and pushes multiples lower.
Microsoft (MSFT) flat after a UK regulator opened a probe into its business software ecosystem. No immediate P&L impact, but it extends the bundling/defaults/integration overhang. In this tape, slow regulatory risk is dead weight.
Super Micro Computer (SMCI) down despite strong sales. That’s the regime: good numbers don’t protect crowded AI infrastructure names when funds are cutting gross. This looked more like positioning and drawdown control than a demand signal.
DocuSign (DOCU) flat after Bank of America restarted with Underperform. The muted move says the skepticism is already priced, or no one wants to take a big swing without a clear catalyst. Application software is still in “prove it” mode.
Wise (WISE) flat after launching a new UK account aimed at daily banking users. Moving toward primary-account behavior is strategic, but the market won’t pay for product ambition without visible monetization—or a better bid under growth.
Single names
With index sentiment cautious, the cleanest moves were idiosyncratic.
McCormick (MKC) jumped on reported merger talks tied to Unilever’s food business (not confirmed in the latest earnings). The market will still pay for consolidation in staples: shelf power and synergies are tangible. But “not confirmed” is the risk—if the chatter fades, the pop can unwind quickly.
Elsewhere it was balance-sheet and compliance headlines. Not dramatic, but they set the risk framework:
SCYNEXIS (SCYX) flat after a $40M private placement. In biotech, that’s runway plus dilution. Flat trading suggests the cash need wasn’t a surprise and terms didn’t shock.
Plus Therapeutics (PLSE): 1-for-25 reverse split. That’s exchange-compliance and optics. Liquidity can get funky, and most buyers wait for post-split trading to settle.
SunPower (SPWR) flat after delaying its 10-K while pointing to “significant positive changes” expected in FY2025 results. Filing delays are headline risk by default—controls, audit friction, and restatement fear come with the territory even if management is upbeat.
Other updates were mostly maintenance: Latch (LATCH) flat after full-year results (cash burn and retention still the questions), AlTi Global named Nancy Curtin interim CEO (transition risk until a permanent plan lands), Amylyx Pharmaceuticals finished Phase 3 Lucidity enrollment for Avexitide (timeline milestone, not an efficacy moment), and private markets kept feeding compute-adjacent themes with Starcloud raising $170M for space data centers.
What mattered
- The tape stayed fragile: rallies sold, duration got trimmed.
- Supply risk stayed sticky in energy, and Europe’s Germany vs. France power-price gap made it real.
- Tech was a grind lower: regulatory overhangs plus de-grossing pressure.
- The best single-name action came from deals, financing, and compliance—not “great fundamentals.”
The market bought risk control, not stories.